Download presentation
Presentation is loading. Please wait.
Published byEdmund Dickerson Modified over 9 years ago
1
European Patients’ Academy on Therapeutic Innovation Aspects of pharmacovigilance: Periodic Safety Update Reports (PSURs)
2
European Patients’ Academy on Therapeutic Innovation PSURs are pharmacovigilance documents intended to provide an evaluation of the benefit-risk balance of a medicinal product for submission by a Market Authorisation Holder (MAH) at defined points of time during the post-authorisation phase. The European Medicines Agency maintains a list of EU reference dates (EURDs) and frequency of submission of PSURs for active substances contained in medicines in the EU. 2 What are Periodic Safety Update Reports (PSURs)?
3
European Patients’ Academy on Therapeutic Innovation The EMA carries out single assessments of related PSURs for medicines containing the same active substances or combinations of active substances. Single assessments occur even though the active substances in question may be contained in medicines subject to different marketing authorisations or authorised in more than one Member State. The single assessment process aims to harmonise and strengthen the safety and benefit-risk review of medicines across the European Economic Area. 3 Assessment of the PSUR
4
European Patients’ Academy on Therapeutic Innovation The main objective of the PSUR is to present a comprehensive, concise, and critical analysis of the benefit-risk balance of the medicinal product, taking into account new or emerging information in the context of cumulative information on benefit-risk in the post- marketing environment 4 Scope of the PSUR
5
European Patients’ Academy on Therapeutic Innovation European Medicines Agency (2013). EMA/816292/2011 Rev 1. Guideline on good pharmacovigilance practices (GVP): Module VII – Periodic safety update report. Retrieved 29 September, 2015, from http://www.ema.europa.eu/docs/en_GB/document_librar y/Scientific_guideline/2013/04/WC500142468.pdf http://www.ema.europa.eu/docs/en_GB/document_librar y/Scientific_guideline/2013/04/WC500142468.pdf 5 Further reading
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.